Replimune Group, Inc.
Industry: Life Sciences ・ $REPL on Nasdaq
Insider Sale
+$245,394
-2.49%
Shares
Shares Volume: 37,928 Shares
Average Share Price: $6.47
INSIDER
Astley-Sparke Philip
Executive Chairman (Director)
reported on May 20 2024
traded on May 16 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,487,350 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $245,394.16 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 12 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $167,565.39 |
| COMPANY PREVIOUS TRADES |